Karachi, May 30, 2020: The Searle Company Limited has successfully entered into an exclusive licensing & marketing agreement with Beximco Pharmaceuticals, Bangladesh. Searle is the first and only pharmaceutical company in Pakistan to source the generic version of Remdesivir for the treatment of Covid-19 through the Patient Access Program. Remdesivir is a direct acting broad-spectrum…
“Ferozsons Laboratories from Pakistan is amongst the five companies to produce Remdesivir for distribution in 127 countries” Karachi, May 13, 2020: Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply of Remdesivir. The agreements allow the companies – Cipla Ltd, Ferozsons Laboratories, Hetero…
Islamabad, April 15, 2019: Senator Mian Muhammad Ateeq Shaikh, Chairperson, Senate Committee on National Health Services Regulations and Coordination said Prime Minister Imran Khan should uphold its commitment to the public of Pakistan and should take concrete measures to reverse the price hike of drugs immediately. He said if the Prime Minister does not take…